By reconstructing the Notch protein for mesenchymal stem cells (MSCs), an artificial receptor for recognizing Her2 (+) tumor cells and a response structure for producing/deploying endostatin were customized to it, creating an intelligent drug based on MSCs (iMSCEndostatin). This evidence concerns the gene ERBB2 and neoplasm.